nach oben

Journal of Bone and Mineral Metabolism

Erschienen in:

01.07.2014 | Original Article

Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients

verfasst von: J. Mohiti-Ardekani, H. Soleymani-Salehabadi, M. B. Owlia, A. Mohiti

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to investigate the relationship between fasting serum leptin, adiponectin and resistin levels and bone mineral density (BMD) in osteoporosis patients and a non-osteoporosis control group. We studied 81 non-diabetic osteoporosis patients (92 % female, 8 % male; mean age 54.5 ± 15.5 years and body mass index [BMI] 28.2 ± 4.6) and 120 non-diabetic individuals with normal BMD as controls (86 % female, 14 % male; mean age 39.7 ± 10.4 years and BMI 28.8 ± 4.4). BMD was studied by dual-energy X-ray absorptiometry from the lumbar spine (L1–L4) and femoral neck and fasting blood samples were taken for biochemical measurement of fasting blood glucose, leptin, adiponectin and resistin. Fasting levels of plasma adiponectin had a significant negative correlation with BMD of the femoral neck and lumbar spine in the osteoporosis group (r = −0.478, P = 0.003, r = −0.513, P = 0.023) but not in the non-osteoporosis group (r = −0.158, P = 0.057, r = −0.23, P = 0.465). Fasting plasma levels of resistin were significantly correlated only with femur BMD in the osteoporosis group, and not significantly correlated with lumbar spine BMD (r = −0.244, P = 0.048 vs r = 0.276, P = 0.56). Leptin did not have a significant correlation with BMD in either the osteoporosis or non-osteoporosis groups (P > 0.05). Adiponectin had a significant negative correlation with BMD of the lumbar spine and femoral neck. The correlation between leptin and resistin are not inconclusive.

Lim S, Joung H, Shin CS, Lee HK, Kim KS, Shin EK, Kim HY, Lim MK, Cho SI (2004) Body composition changes with age have gender-specific impacts on bone mineral density. Bone 35:792–798PubMedCrossRef

Felson DT, Zhang Y, Hannan MT, Anderson J (1993) Effects of weight and body mass index on bone mineral density in men and women. J Bone Miner Res 8:567–573PubMedCrossRef

Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES (1995) Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118–1123PubMed

Lenchik L, Register TC, Lohman K, Hsu F-C, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646–651PubMedCrossRef

won Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E (2007) Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int 18:1337–1344CrossRef

Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K (1997) Analysis of an expression profile of genes in the human adipose tissue. Gene 190:227–235PubMedCrossRef

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura Nakamura T et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83PubMedCrossRef

Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881PubMedCentralPubMedCrossRef

Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953PubMedCrossRef

10.

Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T (2007) Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8:51–62PubMedCentralPubMedCrossRef

11.

Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842–849PubMedCrossRef

12.

Williams GA, Wang Y, Callon KE, Watson M, Lam JB, Lin JM, Janice BB, Costa JL, Orpe A, Broom N, Naot D, Reid IR, Cornish J (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603–3610PubMedCrossRef

13.

Brennan AM, Mantzoros CS (2006) Drug insight: the role of leptin in human physiology and pathophysiology-emerging clinica applications. Nat Rev Endocrinol 2:318–327

14.

Thomas T, Burguera B, Melton LJ, Atkinson E, Riggs BL, Khosla S (2004) Relationship of serum leptin levels with body composition, sex steroid, and insulin levels in women and men. Metabolism 9:1278–1284

15.

Burguera B, Hofbau L, Thomas L, Gori F, Lamsam J et al (2001) Leptin reduces ovariectomy-induced bone loss. Endocrinology 142:3546–3553PubMedCrossRef

16.

Ducy P, Amling M, Takeda S, Priemel M, Schilling AF et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207PubMedCrossRef

17.

Jürimäe J, Jürimäe T, Leppik A, Kums T (2008) The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 26:618–623PubMedCrossRef

18.

OdabaI E, Ozata M, Turan M, Bingo N, Yonem A, Cakir B, Kutlu M, Ozdemir IC (2000) Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170–173CrossRef

19.

Gonnelli S, Caffarelli C, Del Santo K, Cadirni A, Guerriero C, Lucani B, Franci B, Nuti R (2008) The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 83:55–60PubMedCrossRef

20.

Ozkurt B, Ozkurt ZN, Altay M, Aktekin CN, Caðlayan O, Tabak Y (2009) The relationship between serum adiponectin level and anthropometry bone mass osteoporotic fracture skin postmeno-pausal women. Eklem Hastalik Cerrahisi 20:78–84PubMed

21.

Canhao H, Fonseca JE, Caetano-Lopes J, Saldanha C, Queiroz MV (2008) Assessment of laboratory measurements and -308 TNF gene promoter polymorphisms in normal bone mineral density. Clin Rheumatol 27:301–307PubMedCrossRef

22.

Kontogianni MD, Dafni UG, Routsias G, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546–551PubMedCrossRef

23.

Pang XD, Xian H, Zhao Q, Wu XP, Sun ZQ, Liao EY (2008) Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 387:31–35CrossRef

24.

Jürimäe J, Jürimäe T (2007) Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos Int 18:1253–1259PubMedCrossRef

25.

Jurima J, Rembel K, Jurimae T, Rehand M (2005) Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 37:297–302CrossRef

26.

Ealey KN, Kaludjerovic J, Archer MC, Ward WE (2008) Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood) 233:1546–1553CrossRef

27.

Richards JB, Valdes AM, Burling K, Perks UC, Spector TD (2007) Serum adiponectin and bone mineral density in women. ICEM 92:1517–1523

28.

Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M et al (2001) Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. JCEM 86:5273–5276PubMed

29.

Zhong N, Wu XP, Xu ZR, Wang AH, Luo XH, Cao XZ, Xie H, Shan PF, Liao EY (2005) Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Clin Chim Acta 351:161–168PubMedCrossRef

30.

Parm AL, Jürimäe J, Saar M, Pärna K, Tillmann V, Maasalu K, Neissaar I, Jürimäe T (2011) Plasma adipocytokine and ghrelin levels in relation to bone mineral density in prepubertal rhythmic gymnasts. J Bone Miner Metab 9:717–724CrossRef

31.

Tamura T, Yoneda M, Yamane K, Nakanishi S, Nakashima R, Okubo M, Kohno N (2007) Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism 56:623–628PubMedCrossRef

32.

Oshima K, Nampei AM, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331:520–526PubMedCrossRef

33.

Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648–1656PubMedCrossRef

34.

Kajimura D, Lee HW, Riley KJ, Arteaga-Solis E, Ferron M, Zhou B, Clarke CJ, Hannun YA, Depinho RA, Guo EX, Mann JJ, Karsenty G (2013) Adiponectin regulates bone mass via opposite central and peripheral mechanism through FoxO1. Cell Metab 17:901–915PubMedCentralPubMedCrossRef

35.

Shinoda Y, Yamaguchi M, Ogata N (2006) Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 99:196–208PubMedCrossRef

36.

Atalay A, Elic H, Kayadibi N, Nurettin A (2012) Diagnostic utility of osteocalcin, under carboxylated osteocalcin and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med 32:23–30PubMedCentralPubMedCrossRef

37.

Ochoa S, Arantazu F, Diego R, Rebeca M, Raya M, Manuel M (2012) Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with reloxifene or alendronate. Menopause 19:172–177CrossRef

38.

Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 21:56–61

39.

Chanprasertyothin S, Piaseu N, Chailurkit L, Rajatanavin R, Ongphiphadhanakul B (2005) Association of circulating leptin with bone mineral density in males and females. J Med Assoc Thai 88:655–659PubMed

40.

Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin- like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113–117PubMedCrossRef

41.

Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T et al (2002) Genetic variation in the gene encoding adiponectin in associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536–540PubMedCrossRef

Titel: Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients
verfasst von: J. Mohiti-Ardekani
H. Soleymani-Salehabadi
M. B. Owlia
A. Mohiti
Publikationsdatum: 01.07.2014
Verlag: Springer Japan
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 4/2014
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-013-0511-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Frauen bekommen seltener eine intensive Statintherapie

30.04.2024 Statine Nachrichten

Frauen in den Niederlanden erhalten bei vergleichbarem kardiovaskulärem Risiko seltener eine intensive Statintherapie als Männer. Ihre LDL-Zielwerte erreichen sie aber fast ähnlich oft.

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Palliative treatment of bone metastases with samarium-153 EDTMP at onset of pain

Osteoprotegerin and fractures in men and women with chronic kidney disease

Millimeter wave promotes the synthesis of extracellular matrix and the proliferation of chondrocyte by regulating the voltage-gated K+ channel

Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update